Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) is a Shell Companies company in the Financial Services sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $649M; returns 1 day +0.0%, 1 week +0.1%.

Drugs Made In America Acquisition II Corp. (DMII) is a Special Purpose Acquisition Company (SPAC) incorporated in the Cayman Islands. The company has no significant operations or revenue, as its sole purpose is to effect a merger, share exchange, asset acquisition, or similar business combination with one or more businesses.

DMII financial model: income statement, cash flow and balance sheet